^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | B Acute Lymphoblastic Leukemia |
| Drug: | Asparlas (calaspargase pegol-mknl) (Asparagine depleter, Aspartate-ammonia ligase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
11/29/2023
Excerpt:
ASPARLAS is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years.
